Literature DB >> 16023673

Oxidative refolding of amyloidogenic variants of human lysozyme.

Rachel Wain1, Lorna J Smith, Christopher M Dobson.   

Abstract

The oxidative refolding of human lysozyme and its two best characterised amyloidogenic variants, Ile56Thr and Asp67His, has been investigated in vitro by means of the concerted application of a range of biophysical techniques. The results show that in each case the ensemble of reduced denatured conformers initially collapses into a large number of unstructured intermediates with one or two disulphide bonds, the majority of which then fold to form the native-like three-disulphide intermediate, des-[77-95]. The slow step in the overall folding reaction involves the rearrangement of the latter to the fully oxidised native protein containing four disulphide bonds. The Ile56Thr and Asp67His variants were found to fold faster than the wild-type protein by a factor of 2 and 3 respectively, an observation that can be attributed primarily to the reduction in the barriers to conformational rearrangements that results from both the mutations. The efficient folding of these variants despite their enhanced propensities to aggregate when compared to the wild-type protein is consistent with their ability to be secreted in sufficient quantities to give rise to the systemic amyloidoses with which they are associated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023673     DOI: 10.1016/j.jmb.2005.06.035

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Mechanism of gemini disulfide detergent mediated oxidative refolding of lysozyme in a new artificial chaperone system.

Authors:  Marc Potempa; Mathias Hafner; Christian Frech
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

2.  Arsenic(III) species inhibit oxidative protein folding in vitro.

Authors:  Danny Ramadan; Pumtiwitt C Rancy; Radhika P Nagarkar; Joel P Schneider; Colin Thorpe
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

3.  A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.

Authors:  Erwin De Genst; Pak-Ho Chan; Els Pardon; Shang-Te D Hsu; Janet R Kumita; John Christodoulou; Linda Menzer; Dimitri Y Chirgadze; Carol V Robinson; Serge Muyldermans; André Matagne; Lode Wyns; Christopher M Dobson; Mireille Dumoulin
Journal:  J Phys Chem B       Date:  2013-09-24       Impact factor: 2.991

4.  Native-state stability determines the extent of degradation relative to secretion of protein variants from Pichia pastoris.

Authors:  Graham Whyteside; Marcos J C Alcocer; Janet R Kumita; Christopher M Dobson; Maria Lazarou; Richard J Pleass; David B Archer
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

5.  Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.

Authors:  Janet R Kumita; Linda Helmfors; Jocy Williams; Leila M Luheshi; Linda Menzer; Mireille Dumoulin; David A Lomas; Damian C Crowther; Christopher M Dobson; Ann-Christin Brorsson
Journal:  FASEB J       Date:  2011-09-29       Impact factor: 5.191

6.  A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.

Authors:  Catarina S H Jesus; Zaida L Almeida; Daniela C Vaz; Tiago Q Faria; Rui M M Brito
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.